Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel Bradbury, Robert Epstein, Roy Whitfield, Francis deSouza, and Others

Premium

Illumina stockholders have voted to re-elect four members of its board of directors, approving three-year terms on the board for Daniel Bradbury, Robert Epstein, and Roy Whitfield, and a two-year term for President Francis deSouza.


Singulex has appointed Peter Heseltine as chief medical officer. Heseltine is professor of clinical medicine at the University of California, Irvine. Previously, he was senior vice president and chief medical officer at Prometheus Laboratories. He also held executive positions at Beckman Coulter and Quest Diagnostics.


Enzo Biochem has appointed James O'Brien as senior VP of finance, succeeding Andrew Crescenzo, who is leaving the company. Enzo also said that former Chief Operations Officer Andrew Whiteley has resigned.

O'Brien most recently was VP and corporate controller for Actavis; has held senior finance posts at Nycomed US, Aptuit, Purdue Pharma, and Bristol Myers Squibb; and began his career as an accountant at Pricewaterhouse Coopers.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.